2188 ⎘
Genetically modified animals; Animals genetically altered by homologous recombination inducing loss of function, i.e. knock out heterozygous knock out animals displaying phenotype
TRANSGENIC ANIMALS AND RECOMBINANT HOST CELLS COMPRISING SPECIFIC GENE VARIANTS AND METHODS OF CREATING SAME
#2TRANSGENIC ANIMAL PHENOTYPING PLATFORM AND USES THEREOF
#3GENE THERAPY FOR HAPLOINSUFFICIENCY
#4INHIBITORS OF THE IRE-1/XBP-1 PATHWAY AND METHODS OF USING THEREOF
#5METHODS AND COMPOSITIONS FOR SEXING AND STERILIZATION IN DROSOPHILA SUZUKII AND AEDES AEGYPTI
#6TRANSGENIC ANIMAL PHENOTYPING PLATFORM AND USES THEREOF
#7Gene therapy for haploinsufficiency
#8LINCRNA-DEFICIENT NON-HUMAN ANIMALS
#9MONOGENIC OR POLYGENIC DISEASE MODEL ORGANISMS HUMANIZED WITH TWO OR MORE GENES
#10NON-HUMAN ALZHEIMER'S DISEASE MODEL ANIMAL AND METHOD FOR PRODUCING SAME
#11MODIFIED SALMON WHICH PRODUCE STERILE OFFSPRING
#12Application of a fragment of an isolated nucleotide sequence in construction of non-mineralized intermuscular bone of
#13GENETICALLY MODIFIED NON-HUMAN ANIMAL WITH HUMAN OR CHIMERIC IL33
#14Rodent Model Of Increased Bone Mineral Density
#15A GENETIC MOUSE MODEL OF AUTOIMMUNE ADVERSE EVENTS AND IMMUNE CHECKPOINT BLOCKADE THERAPY
#16NON-HUMAN ANIMAL EXHIBITING DIMINISHED UPPER AND LOWER MOTOR NEURON FUNCTION AND SENSORY PERCEPTION
#17Genetically modified non-human animal with human or chimeric LAG3
#18MODELING TDP-43 PROTEINOPATHY
#19LOSS OF FUNCTION RODENT MODEL OF SOLUTE CARRIER 39 MEMBER 5
#20ADENO-ASSOCIATED VIRAL VECTORS FOR TREATING MUCOLIPIDOSIS TYPE II
#21METHOD FOR CONSTRUCTING MOUSE MODEL WITH CONDITIONAL KNOCKOUT OF TMEM30A GENE FROM PANCREATIC BETA CELL, AND USE THEREOF
#22Transgenic animal phenotyping platform and uses thereof
#23Inhibitors of the IRE-1/XBP-1 pathway and methods of using thereof
#24Gene therapy for haploinsufficiency
#25GENETICALLY STERILE ANIMALS
#26NON-HUMAN ANIMAL EXHIBITING DIMINISHED UPPER AND LOWER MOTOR NEURON FUNCTION AND SENSORY PERCEPTION
#27METHOD FOR ESTABLISHING A NON-HUMAN MAMMALIAN ANIMAL MODEL SUFFERING FROM OBESITY OR RELATED DISEASE AND USE THEREOF
#28Non-Human Animals Comprising SLC30A8 Mutation And Methods Of Use
#29Oncogenic Models Based on Delivery and Use of the CRISPR-Cas Systems, Vectors and Compositions
#30Medical use of CREG protein
#31Chimaeric Surrogate Light Chains (SLC) Comprising Human VpreB
#32Delivery, use and therapeutic applications of the CRISPR-cas systems and compositions for modeling mutations in leukocytes
#33Compositions and methods for treating bone diseases
#34Method for producing non-human large mammal or fish each capable of producing gamete originated from different individual
#35TAFA4 COMPOUNDS AND USES THEREOF FOR TREATING PAIN
#36METHODS OF CHARACTERIZING E-SYT2 INHIBITORS, E-SYT2 INHIBITORS, AND METHODS OF USE
#37Modulation and detection of a neuronal alternative splicing regulatory network for treatment and diagnosis of neurological disorders
#38PERFORIN 2 DEFENSE AGAINST INVASIVE AND MULTIDRUG RESISTANT PATHOGENS
#39Methods of treating fragile X syndrome and related disorders
#40Method for screening gene expression in lincRNA-deficient mice or rats
#41Animal model and method for studying gene-gene interactions
#42Non-human animal exhibiting diminished upper and lower motor neuron function and sensory perception
#43Domain 5 of CD163 for use in antiviral compositions against PRRS, and transgenic animals
#44TAFA4 compounds and uses thereof for treating pain
#45Inhibitors of the IRE-1/XBP-1 pathway and methods of using thereof
#46Animal model for type 2 diabetes and obesity
#47Methods and compositions for treating pain
#48Chimaeric surrogate light chains (SLC) comprising human VpreB
#49Transgenic pig models of cystic fibrosis
#50ANF-RGC in-gene knock-out animal
#51METHOD OF TREATING NEURODEGENERATIVE DISEASE
#52GLOBAL NAV1.7 KNOCKOUT MICE AND USES
#53RSPONDIN-3 INHIBITION IN BONE DISORDERS
#54G-Protein Coupled Receptor 30 (GPR30) transgenic animals as a model for cardiovascular diseases
#55METHODS AND COMPOSITIONS FOR TREATING FUS1 RELATED DISORDERS
#56Transgenic Animal Model of Cancer and Methods of Use
#57Therapeutic or prophylactic agent, detection method and detection agent for metabolic syndrome, and method for screening of candidate compound for therapeutic agent for metabolic syndrome
#58Method of identifying a compound for preventing and/or treating an autoimmune disease
#59GRP78 AND TUMOR ANGIOGENESIS
#60Use of FGF-18 Protein, Target Proteins and Their Respective Encoding Nucleotide Sequences to Induce Cartilage Formation
#61DNA encoding polypeptide capable of modulating muscle-specific tyrosine kinase activity
#62Use of Fgf-18 Protein, Target Proteins and Their Respective Encoding Nucleotide Sequences to Induce Cartilage Formation